Moreover, after treatment with BIRC5 inhibitor (YM155), the proliferation ability of SCLC cells decreased and apoptosis increased, which is consistent with the siRNA related experimental results (Fig. 7). This evidence concerns the gene BIRC5 and small cell lung carcinoma.